Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials

MB12066 is a molecule derived from β-lapachone that shown effects on obesity in previous studies. The present studies were conducted to evaluate the tolerability and pharmacokinetics (PK) of MB12066 after the oral administration of single and multiple doses to healthy volunteers. The study comprised...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seokuee, Lee, SeungHwan, Cho, Joo-Youn, Yoon, Seo Hyun, Jang, In-Jin, Yu, Kyung-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683780/
https://www.ncbi.nlm.nih.gov/pubmed/29158665
http://dx.doi.org/10.2147/DDDT.S151269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683780/
https://www.ncbi.nlm.nih.gov/pubmed/29158665
http://dx.doi.org/10.2147/DDDT.S151269

Ejemplares similares